Axiora Medical
Axiora Medical
Primary clinical systems deployed in public and private medical facilities across Kazakhstan.
The healthcare system of Kazakhstan is undergoing a systematic structural modernization. Governed by the national healthcare development frameworks, both state-backed clinical institutions and rapidly growing private hospital networks in urban hubs like Almaty, Astana, and Shymkent are actively upgrading their trauma care facilities. Central to this clinical evolution is the shift from open reduction internal fixation (ORIF) towards minimally invasive osteosynthesis procedures.
Cannulated screws represent a key clinical instrument in this technological pivot. These orthopedic implants—characterized by a hollow central shaft (cannulation) that enables precise insertion over a guide wire—are in high demand across Kazakhstan's regional clinical centers. The expansion of localized traumatology divisions and the increasing incidence of geriatric hip fractures and high-energy transport trauma require a stable, high-volume supply of medical-grade implants. Importers and local procurement departments require manufacturing partners that offer regulatory compliance, biocompatible materials, and consistent technical supply lines.
Operating in the Kazakhstan medical sector requires compliance with the unified register rules of the Eurasian Economic Union (EAEU). Historically, national registrations allowed unilateral market entry. However, the current regulatory landscape demands that global exporters transition to the standardized EAEU registration protocols. This standard demands detailed laboratory documentation, technical files, ISO 13485 clinical assessment reports, and toxicology profiles. Axiora Medical Technology supports our Central Asian partners by providing complete registration dossiers to guarantee compliance through Kazakhstan’s National Center for Expertise of Medicines and Medical Devices (NDDA).
The performance of cannulated compression screws in traumatology relies heavily on raw material composition and manufacturing precision. As a global exporter, Axiora utilizes implant-grade titanium alloy (Ti-6Al-4V ELI / ASTM F136) and high-nitrogen stainless steel (316LVM / ASTM F138). These alloys are selected for their combination of tensile strength, fatigue resistance, and biocompatibility, minimizing the risk of adverse tissue reactions and post-operative implant failures.
Preferred for long-term internal fixation due to its low elastic modulus, which matches human cortical bone closer than stainless steel, reducing stress shielding. Its native passive oxide layer provides corrosion resistance against physiological fluids. Anodization treatments create a clean surface barrier and color coding for clinical identification.
Offers high yield strength and ductility, making it suitable for temporary fixation systems or structures subject to heavy load bearing. The vacuum arc remelting process eliminates non-metallic inclusions, ensuring structural integrity under high torque limit stresses during implantation.
Our production facilities implement state-of-the-art multi-axis CNC longitudinal cutting machines to achieve precise tolerances (±0.005 mm). The interior lumen is bored using advanced deep-hole drilling techniques to ensure wall thickness consistency, which prevents structural collapse when subjected to high torsional forces during screw insertion. Axiora’s cannulated screws feature specialized thread configurations:
A professional manufacturer specializing in the research, development, and global supply of high-quality orthopedic implants.
Axiora Medical Technology (China) Co., Ltd. is a professional manufacturer specializing in the research, development, production, and global supply of high-quality orthopedic implants and surgical instruments. Our product portfolio covers trauma fixation systems, spinal implants, joint reconstruction solutions, sports medicine products, and related orthopedic surgical instruments.
Established with a commitment to innovation and precision manufacturing, Axiora integrates advanced CNC machining, automated production lines, and strict quality management systems to deliver reliable products that meet international standards. Our experienced engineering team continuously develops innovative solutions to support surgeons and healthcare providers worldwide.
With strong OEM and ODM capabilities, we provide customized manufacturing services according to customers' drawings, samples, and technical requirements. From product design and prototyping to mass production and packaging, our integrated manufacturing process ensures consistent quality, competitive pricing, and on-time delivery.
Today, Axiora exports its orthopedic products to customers across Europe, North America, South America, the Middle East, Southeast Asia, and Africa, building long-term partnerships with medical device distributors, brand owners, hospitals, and healthcare organizations around the world.
| Operating Factor | Technical & Operational Specifications |
|---|---|
| Company Name | Axiora Medical Technology (China) Co., Ltd. |
| Brand Identity | Axiora Ortho Systems |
| Website Portal | www.axioraortho.com |
| Establishment Year | 2017 |
| Factory Infrastructure Area | 18,600 m² |
| Annual Export Volume | USD 26 Million |
| Direct Export Experience | 8 Years |
| Sectorial Specialization | 15 Years |
| Quality Inspection Threshold | 100% Finished Product Inspection & Incoming Material Testing |
| Scientific Inspection Methods | Coordinate Measuring Machine (CMM), Tensile Testing, Hardness Testing, Surface Roughness Inspection, Salt Spray Testing |
| Dedicated Quality Control Staff | 48 Quality Engineers |
| Business Model | Manufacturer & Exporter (OEM/ODM Solutions) |
| Strategic Markets | Kazakhstan, Central Asia, Europe, North America, Middle East, South America |
| Supply Chain Integration | 1,120 Verified Partners |
| Target Customer Profiles | Medical Device Brands, Importers, Distributors, Regional Hospitals, State Tenders |
| R&D Scope | Reverse Engineering, Custom Prototype Development, Advanced Material Engineering |
| Customization Capabilities | Laser Marking, Anodized Color Coding, Custom Instrument Trays, Specialized Sterile Packaging |
| Product Portfolio Additions (Last Year) | 126 New SKUs Introduced |
| R&D Engineering Cohort | 86 Research Engineers |
In Kazakhstan's clinical environments, surgical demands vary based on patient demographics and trauma profiles. Axiora provides customized orthopedic implant systems to meet these requirements. The micro-mechanics of our screws support a range of osteosynthesis applications:
Typically treated with 6.5mm or 7.3mm cannulated screws configured in a parallel triangular pattern. This configuration resists rotational shear forces, helping prevent nonunion and avascular necrosis in elderly osteoporotic populations across clinics in Nur-Sultan/Astana.
Uses 4.0mm and 4.5mm partially threaded cannulated screws. They are deployed to treat calcaneal intra-articular fractures, ensuring compression without disrupting soft tissue attachments in active, working-age patients.
Provides reconstruction of the tibial plateau, patellar fractures, and femoral condyle damage using variable thread pitch compression screws that sink below the cartilage surface to avoid joint irritation.
Implant success depends heavily on the tools used during surgery. Axiora’s multi-functional surgical drill and battery-powered saw systems are designed to operate alongside our cannulated screw sets. Quick-connect couplings allow surgeons to transition from guide-wire placement to pre-drilling and final screw insertion, minimizing operating room times and reducing anesthesia-related risks.
Axiora Medical Technology's R&D focus is directed toward functional material coatings and digital integration within trauma surgery. Our current development pipeline includes several key technologies:
Explore our expanded orthopedic product catalog, certified for imports and clinical use in the Kazakhstan market.
Technical and regulatory information for medical device importers and clinical institutions in Kazakhstan.
Our cannulated screws are manufactured using high-grade medical alloys: Titanium Alloy Ti-6Al-4V ELI (conforming to ASTM F136 / ISO 5832-3) and Vacuum Arc Remelted Stainless Steel 316LVM (conforming to ASTM F138 / ISO 5832-1). These raw materials are selected to guarantee mechanical performance, high torque limits, and long-term biocompatibility in osteosynthesis.
We assist our local distributors by providing comprehensive regulatory dossiers. This includes ISO 13485 certification, CE marking certificates (Class IIb/III), materials analysis reports, mechanical evaluation data (tensile and torque limits), and biocompatibility studies. This documentation supports the registration process through the National Center for Expertise of Medicines and Medical Devices (NDDA) under EAEU regulations.
Implements can be supplied in sterile or non-sterile states. Sterile components undergo Gamma irradiation or Ethylene Oxide (EO) sterilization in our Class 10,000 aseptic cleanrooms. They are packed in protective blister packaging to ensure a 5-year sterile shelf life under standard storage conditions.
Yes, we provide OEM and ODM manufacturing services based on engineering drawings, physical samples, and custom surgical requirements. Our R&D team utilizes advanced reverse-engineering and 3D modeling tools to customize parameters such as thread pitch, cannulation diameter, and overall screw lengths.
Standard catalog items are shipped within 15–30 days from confirmation of order. For custom production runs or large OEM batches, lead times range between 45 and 60 days. Delivery is arranged via rail freight (through Urumqi–Dostyk gateways) or air transport to Almaty and Astana airports, depending on the urgent requirements of local surgical units.
Our commitment to precision in manufacturing translates to measurable clinical quality metrics.